Carregant...
Fitxers
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/125353
Human papillomavirus detection in cervical neoplasia attributed to 12 high-risk human papillomavirus genotypes by region
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Background: We estimated the proportion of cervical intraepithelial neoplasia (CIN) cases attributed to 14 HPV types, including quadrivalent (qHPV) (6/11/16/18) and 9-valent (9vHPV) (6/11/16/18/31/33/45/52/58) vaccine types, by region Methods: Women ages 15-26 and 24-45 years from 5 regions were enrolled in qHPV vaccine clinical trials. Among 10,706 women (placebo arms), 1539 CIN1, 945 CIN2/3, and 24 adenocarcinoma in situ (AIS) cases were diagnosed by pathology panel consensus. Results: Predominant HPV types were 16/51/52/56 (anogenital infection), 16/39/51/52/56 (CIN1), and 16/31/52/58 (CIN2/3). In regions with largest sample sizes, minimal regional variation was observed in 9vHPV type prevalence in CIN1 (similar to 50%) and CIN2/3 (81-85%). Types 31/33/45/52/58 accounted for 25-30% of CIN1 in Latin America and Europe, but 14-18% in North America and Asia. Types 31/33/45/52/58 accounted for 33-38% of CIN2/3 in Latin America (younger women), Europe, and Asia, but 17-18% of CIN2/3 in Latin America (older women) and North America. Non-vaccine HPV types 35/39/51/56/59 had similar or higher prevalence than qHPV types in CIN1 and were attributed to 2-11% of CIN2/3. Conclusions: The 9vHPV vaccine could potentially prevent the majority of CIN1-3, irrespective of geographic region. Notwithstanding, non-vaccine types 35/39/51/56/59 may still be responsible for some CIN1, and to a lesser extent CIN2/3. (C) 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Matèries
Matèries (anglès)
Citació
Citació
CASTELLSAGUÉ, Xavier, AULT, Kevin a., BOSCH JOSÉ, Francesc xavier, BROWN, Darron, CUZICK, Jack, FERRIS, Daron g., JOURA, Elmar a., GARLAND, Suzanne m., GIULIANO, Anna r., HERNÁNDEZ AVILA, Mauricio, HUH, Warner, IVERSEN, Ole-erik, KJAER, Susanne krüger, LUNA, Joaquin, MONSONEGO, Joseph, MUÑOZ, Nubia, MYERS, Evan, PAAVONEN, Jorma, PITISUTTIHUM, Punnee, STEBEN, Marc, WHEELER, Cosette m., PEREZ, Gonzalo, SAAH, Alfred, LUXEMBOURG, Alain, SINGS, Heather l., VELICER, Christine. Human papillomavirus detection in cervical neoplasia attributed to 12 high-risk human papillomavirus genotypes by region. _Papillomavirus Research_. 2016. Vol. 2, núm. 61-69. [consulta: 15 de gener de 2026]. [Disponible a: https://hdl.handle.net/2445/125353]